Page 6 - String Technologies News Today

NanoString Will Immediately Appeal Preliminary Injunction Temporarily Blocking NanoString’s Ability to Market and Sell CosMx Spatial Molecular Imager Products for RNA Detection within UPC Member...

Morgan Stanley Global Healthcare Conference Baird Global Healthcare Conference September 12 and 13, 2023 ...

/PRNewswire/ -- The "MicroRNA Market Size, Share & Trends Analysis Report By Products & Services (Profiling, Localization, & Quantification), By Application...

SEATTLE--(BUSINESS WIRE)--Aug 28, 2023--

Platinum Investment Management Ltd. lowered its holdings in shares of NanoString Technologies, Inc. (NASDAQ:NSTG – Free Report) by 2.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,229,803 shares of the biotechnology company’s stock after selling 29,164 shares during the period. Platinum Investment […]

NanoString Technologies (NASDAQ:NSTG – Get Free Report) and Nephros (NASDAQ:NEPH – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, earnings, analyst recommendations and dividends. Insider & Institutional Ownership 94.1% of NanoString Technologies […]

August Issue of Lancet Medical Journal Features Breakthrough Study Decoding Immunological Challenges of Xenotransplantation ...

Stock analysts at StockNews.com assumed coverage on shares of NanoString Technologies (NASDAQ:NSTG – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. NSTG has been the topic of several other reports. Morgan Stanley dropped their price target on NanoString […]

NanoString Technologies, Inc. , a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from...

NanoString Technologies (NASDAQ:NSTG – Get Free Report) released its earnings results on Thursday. The biotechnology company reported ($0.92) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.70) by ($0.22), Briefing.com reports. The firm had revenue of $44.16 million during the quarter, compared to analyst estimates of $42.45 million. NanoString Technologies had […]